Talk
Stephanie Frisch, NP + Jana McNulty, RPh
Feedback
-
Joining by phone ONLY:
+1 204 272 7920 Canada
+1 438 809 7799 Canada
+1 587 328 1099 Canada
+1 647 374 4685 Canada
+1 647 558 0588 Canada
+1 778 907 2071 Canada
+1 780 666 0144 Canada
Meeting ID: 986 8740 4228
Find your local number: https://echo.zoom.us/u/kdeYJ8w8oS
Press *6 to mute your line when not speaking
Password: boreal
Session Resources
From Dan's case:
Trigeminal Neuralgia diagnostic criteria - IHS Classification ICHD-3
Marbach J. J. (1993). Is phantom tooth pain a deafferentation (neuropathic) syndrome? Part I: Evidence derived from pathophysiology and treatment. Oral surgery, oral medicine, and oral pathology, 75(1), 95–105.
From Jana's talk:
Opioid manager - Centre for Effective Practice (link to the Opioid Manager - page 3 has the table with the opioid conversion chart + instructions on a rotation/switch)
Management of Chronic Non-Cancer Pain - Centre for Effective Practice
Management of Chronic Non-Cancer Pain (Appendix) - Centre for Effective Practice
Chin, T., Huyghebaert, T., Svrcek, C., & Oluboka, O. (2022). Individualized antidepressant therapy in patients with major depressive disorder: Novel evidence-informed decision support tool. Canadian family physician Medecin de famille canadien, 68(11), 807–814.
Wager, T. D., Scott, D. J., & Zubieta, J. K. (2007). Placebo effects on human mu-opioid activity during pain. Proceedings of the National Academy of Sciences of the United States of America, 104(26), 11056–11061. https://doi.org/10.1073/pnas.0702413104
Wellness Together Canada which offers 24/7 counselling, free of charge:
Cannabis : Potential increase in anxiety over time:
Xue S, Husain MI, Zhao H, Ravindran AV. Cannabis Use and Prospective Long-Term Association with Anxiety: A Systematic Review and Meta-Analysis of Longitudinal Studies: Usage du cannabis et association prospective à long terme avec l’anxiété: une revue systématique et une méta-analyse d’études longitudinales. The Canadian Journal of Psychiatry. 2021;66(2):126-138. doi:10.1177/0706743720952251
From Jana in chat:
For patients who have multiple risk factors for NSAID-related GI toxicity, options include therapy with a coxib or a nonselective NSAID in combination with a PPI (or misoprostol)
RFs:
-History of an uncomplicated ulcer
-Age >65 years
-High-dose NSAID therapy
-Concurrent use of aspirin (including low dose), glucocorticoids, or anticoagulants